Your browser doesn't support javascript.
loading
Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
Wang, Qian; Qian, Junyan; Li, Mengtao; Zhang, Xiao; Wei, Wei; Zuo, Xiaoxia; Zhu, Ping; Ye, Shuang; Zhang, Wei; Zheng, Yi; Qi, Wufang; Li, Yang; Zhang, Zhuoli; Ding, Feng; Gu, Jieruo; Liu, Yi; Huang, Can; Zhao, Jiuliang; Liu, Yongtai; Tian, Zhuang; Wang, Yanhong; Zhang, Miaojia; Zeng, Xiaofeng.
Afiliação
  • Wang Q; Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Qian J; Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Li M; Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Zhang X; Department of Rheumatology, Guangdong General Hospital, Guangzhou, China.
  • Wei W; Department of Rheumatology, Tianjin Medical University General Hospital, Tianjin, China.
  • Zuo X; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, China.
  • Zhu P; Department of Clinical Immunology, PLA Specialized Research Institute of Rheumatology & Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Ye S; Department of Rheumatology, Ren Ji Hospital South Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang W; Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zheng Y; Department of Rheumatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Qi W; Department of Rheumatology, The First Central Hospital, Tianjin, China.
  • Li Y; Department of Rheumatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhang Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Ding F; Department of Rheumatology, Qilu Hospital of Shandong University, Jinan, China.
  • Gu J; Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Liu Y; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
  • Huang C; Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Zhao J; Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Liu Y; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Tian Z; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Wang Y; Department of Epidemiology and Bio-statistics, Institute of Basic Medical Sciences, China Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhang M; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Zeng X; Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing 100730, China.
Ther Adv Chronic Dis ; 13: 20406223221112528, 2022.
Article em En | MEDLINE | ID: mdl-35898921

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Chronic Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Chronic Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China